Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 3/20 | 0.52 |
| ▸ | HCAR2 | Q8TDS4 | 8/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL624268 | 0.98 | MGLL (0.54) | MGLLHCAR2ALDH1A1TP53CYP3A4 | |
| SCHEMBL422856 | 0.98 | MGLL (0.54) | MGLLHCAR2ALDH1A1TP53CYP3A4 | |
| SCHEMBL422857 | 0.98 | MGLL (0.54) | MGLLHCAR2ALDH1A1TP53CYP3A4 | |
| Ethane SCHEMBL2120677 | 0.95 | MGLL (0.51) | MGLLHCAR2ALDH1A1TP53CYP3A4 | |
| Propane SCHEMBL4901497 | 0.93 | HCAR2 (0.53) | MGLLHCAR2ALDH1A1TP53CYP3A4 | |
| Butane SCHEMBL442322 | 0.91 | HCAR2 (0.53) | MGLLHCAR2ALDH1A1TP53CYP3A4 | |
| SCHEMBL624267 | 0.90 | MGLL (0.55) | MGLLALDH1A1TP53CYP3A4 | |
| SCHEMBL268635 | 0.90 | MGLL (0.55) | MGLLALDH1A1TP53CYP3A4 | |
| SCHEMBL268634 | 0.90 | MGLL (0.55) | MGLLALDH1A1TP53CYP3A4 | |
| Propene SCHEMBL10621329 | 0.90 | MGLL (0.48) | MGLLHCAR2ALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6495636-B2 | A 3-(ETHYLENEOXYALKYLOXYALKYL)OXETANE AND DERIVATIVES; COPOLYMERIZED WITH A 1,1-DIFLUOROETHYLENE OR DERIVATIVE; VERY COMPATIBLE AND COPOLYMERIZABLE WITH UNSATURATED COMPOUNDS; WATERPROOFING; RADIATION TRANSPARENT | JSR CORPORATION (JP) | 2002-12-17 | — | — | US | disclosed |
| EP-0939090-B1 | Graft copolymer and process for production thereof | MITSUBISHI CHEM CORP (JP) | 2002-09-18 | — | — | EP | disclosed |
| US-20010002423-A1 | Oxetane compound, oxetane copolymer, and process for producing the oxetane compound | SUGIYAMA NAOKI (JP) | 2001-05-31 | — | — | US | disclosed |
| EP-1095938-A1 | OXETANE COMPOUNDS, OXETANE COPOLYMER, AND PROCESS FOR PRODUCING OXETANE COMPOUNDS | JSR Corporation (JP) | 2001-05-02 | — | — | EP | disclosed |
| EP-0939090-A1 | Graft copolymer and process for production thereof | MITSUBISHI CHEMICAL CORPORATION (JP) | 1999-09-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010002423-A1 | Oxetane compound, oxetane copolymer, and process for producing the oxetane compound | OXER1, PYM1, AFF1 | MGLL 2914/4885HCAR2 3429/4885ALDH1A1 1653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.